Method of treating diabetic nephropathy by administering antibodies to vascular endothelial growth factor B (VEGF-B)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9803008
SERIAL NO

15039606

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides a method of treating diabetic nephropathy in a subject suffering from diabetic nephropathy, the method comprising administering to the subject a compound that inhibits VEGF-B signalling.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CSL LIMITEDMELBOURNE
B-CREATIVE SWEDEN AB556906-5740 HAGERVAGEN 27 BALSTA S-746 34

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Eriksson, Ulf Stockholm, SE 86 482
Falkevall, Annelie Stockholm, SE 6 4
Mehlem, Annika Stockholm, SE 6 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 30, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 30, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00